The CHMP backed orforglipron for weight management and type 2 diabetes. Trial users lost about 5 to 11% of body weight at 72 weeks, per the studies cited.
Recap by typeshit. Full story at Новости GxP.
She talks with Annika Urban about combining GLP-1 treatment with behavioral coaching and telehealth care.
An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
Oddo moved to DKK 305 and HSBC to DKK 280. Novo also shared a CagriSema subgroup analysis showing women lost 25% of body weight at 68 weeks.
MUSC Health suggests the familiar ABCs of heart health may change, with GLP-1 medications now part of cardiovascular prevention for some patients.
A Facebook post credits Novo Nordisk's GLP-1 drugs with strong results in obesity and type 2 diabetes, plus lower risk of other conditions.
LifeMD's chief medical officer says the pill is the same drug with stricter daily rules and possibly more stomach side effects, and cheaper mainly for cash payers.
Loading…